Extensions

Here is a detailed breakdown of the term and family data for U.S. Patent No. 10,468,543.

Patent Term Analysis

• U.S. Patent Number: 10,468,543 B2
• Grant Date: November 5, 2019
• Application Number: 16/296,985
• Filing Date: March 8, 2019

Continuity and Priority Data

This patent is a continuation of a chain of applications, claiming priority back to an application filed in 2013. The chain of priority is as follows:

• This Application (16/296,985): Filed March 8, 2019.
  • This is a continuation of application Ser. No. 15/797,821 (now U.S. Patent No. 10,446,700), filed on October 30, 2017.
• Parent Application (15/797,821):
  • This was a continuation of PCT Application No. PCT/US2016/067977, filed on December 21, 2016.
• Grandparent PCT Application (PCT/US2016/067977):
  • This PCT application claimed priority to U.S. Provisional Application No. 62/270,361, filed on December 21, 2015.
  • It also claimed priority to U.S. Provisional Application No. 62/303,047, filed on March 3, 2016.
• Additional Priority Claims: The patent also claims priority to several earlier applications, establishing an earliest priority date of May 22, 2013, based on U.S. Provisional Application No. 61/826,203. This is the critical date for calculating the patent term.

Patent Term Adjustment (PTA) / Patent Term Extension (PTE)

• Patent Term Adjustment (PTA): There is no Patent Term Adjustment (PTA) indicated for this patent. The USPTO did not identify any administrative delays that would warrant an extension of the patent term.
• Patent Term Extension (PTE): There is no Patent Term Extension (PTE) for this patent. PTE is typically granted for delays in regulatory review for products like pharmaceuticals and is not applicable here.
• Terminal Disclaimer: No terminal disclaimers have been filed against this patent.

Patent Family

This patent is part of a large international patent family. The applications listed below claim priority to the same or related parent applications.

Direct Family Members (Continuations/Divisionals):

• U.S. Patent No. 10,446,700: Parent patent.
• U.S. Patent No. 11,121,271: A continuation application.
• U.S. Patent No. 11,791,432: A continuation application.
• U.S. Patent Application Pub. No. 2023/0215962 A1: A continuation application.
• U.S. Patent No. 12,087,871: A continuation application.
• U.S. Patent No. 12,243,948: A continuation application.

International (PCT) Family Members:

• WO 2014/190189 A2: Published from PCT/US2014/039208.
• WO 2016/081476 A1: Published from PCT/US2015/061120.
• WO 2017/112747 A1: Published from PCT/US2016/067977.

Projected Expiration Date

The term of a U.S. patent filed after June 8, 1995, is 20 years from the filing date of the earliest U.S. non-provisional application to which it claims priority.

• Earliest Non-Provisional Filing Date: The chain of priority goes back to PCT applications, which designate the U.S. The earliest relevant priority date for term calculation is derived from the international application PCT/US2014/039208, which was filed on May 22, 2014.
• Base Term: 20 years from May 22, 2014.
• Calculation: May 22, 2014 + 20 years = May 22, 2034.
• Adjustments:
  • PTA: 0 days
  • PTE: 0 days
  • Terminal Disclaimer: None

Projected Expiration Date: The patent is projected to expire on May 22, 2034, assuming all required maintenance fees are paid on time.